Return to study ST000288 main page

Download data matrix(Metabolomic profiling of AML Cell Lines ESI Positive mode)

Download data matrix(Metabolomic profiling of AML Cell Lines ESI Negative mode)

AnalysisSamplesFactorsUnits
ESI Positive modeLamba_AML193_1Cytarabin Treatment (uM):0Peak area
ESI Positive modeLamba_HL60_1Cytarabin Treatment (uM):0Peak area
ESI Positive modeLamba_Kasumi1_1Cytarabin Treatment (uM):0Peak area
ESI Positive modeLamba_KG1_1Cytarabin Treatment (uM):0Peak area
ESI Positive modeLamba_ME1_1Cytarabin Treatment (uM):0Peak area
ESI Positive modeLamba_MOLM16_1Cytarabin Treatment (uM):0Peak area
ESI Positive modeLamba_MV-411_1Cytarabin Treatment (uM):0Peak area
ESI Positive modeLamba_THP1_1Cytarabin Treatment (uM):0Peak area
ESI Positive modeLamba_AML193_2Cytarabin Treatment (uM):1Peak area
ESI Positive modeLamba_HL60_2Cytarabin Treatment (uM):1Peak area
ESI Positive modeLamba_Kasumi1_2Cytarabin Treatment (uM):1Peak area
ESI Positive modeLamba_KG1_2Cytarabin Treatment (uM):1Peak area
ESI Positive modeLamba_ME1_2Cytarabin Treatment (uM):1Peak area
ESI Positive modeLamba_MOLM16_2Cytarabin Treatment (uM):1Peak area
ESI Positive modeLamba_MV-411_2Cytarabin Treatment (uM):1Peak area
ESI Positive modeLamba_THP1_2Cytarabin Treatment (uM):1Peak area
ESI Positive modeLamba_AML193_3Cytarabin Treatment (uM):10Peak area
ESI Positive modeLamba_HL60_3Cytarabin Treatment (uM):10Peak area
ESI Positive modeLamba_Kasumi1_3Cytarabin Treatment (uM):10Peak area
ESI Positive modeLamba_KG1_3Cytarabin Treatment (uM):10Peak area
ESI Positive modeLamba_ME1_3Cytarabin Treatment (uM):10Peak area
ESI Positive modeLamba_MOLM16_3Cytarabin Treatment (uM):10Peak area
ESI Positive modeLamba_MV-411_3Cytarabin Treatment (uM):10Peak area
ESI Positive modeLamba_THP1_3Cytarabin Treatment (uM):10Peak area
ESI Negative modeLamba_AML193_1Cytarabin Treatment (uM):0Peak area
ESI Negative modeLamba_HL60_1Cytarabin Treatment (uM):0Peak area
ESI Negative modeLamba_Kasumi1_1Cytarabin Treatment (uM):0Peak area
ESI Negative modeLamba_KG1_1Cytarabin Treatment (uM):0Peak area
ESI Negative modeLamba_ME1_1Cytarabin Treatment (uM):0Peak area
ESI Negative modeLamba_MOLM16_1Cytarabin Treatment (uM):0Peak area
ESI Negative modeLamba_MV-411_1Cytarabin Treatment (uM):0Peak area
ESI Negative modeLamba_THP1_1Cytarabin Treatment (uM):0Peak area
ESI Negative modeLamba_AML193_2Cytarabin Treatment (uM):1Peak area
ESI Negative modeLamba_HL60_2Cytarabin Treatment (uM):1Peak area
ESI Negative modeLamba_Kasumi1_2Cytarabin Treatment (uM):1Peak area
ESI Negative modeLamba_KG1_2Cytarabin Treatment (uM):1Peak area
ESI Negative modeLamba_ME1_2Cytarabin Treatment (uM):1Peak area
ESI Negative modeLamba_MOLM16_2Cytarabin Treatment (uM):1Peak area
ESI Negative modeLamba_MV-411_2Cytarabin Treatment (uM):1Peak area
ESI Negative modeLamba_THP1_2Cytarabin Treatment (uM):1Peak area
ESI Negative modeLamba_AML193_3Cytarabin Treatment (uM):10Peak area
ESI Negative modeLamba_HL60_3Cytarabin Treatment (uM):10Peak area
ESI Negative modeLamba_Kasumi1_3Cytarabin Treatment (uM):10Peak area
ESI Negative modeLamba_KG1_3Cytarabin Treatment (uM):10Peak area
ESI Negative modeLamba_ME1_3Cytarabin Treatment (uM):10Peak area
ESI Negative modeLamba_MOLM16_3Cytarabin Treatment (uM):10Peak area
ESI Negative modeLamba_MV-411_3Cytarabin Treatment (uM):10Peak area
ESI Negative modeLamba_THP1_3Cytarabin Treatment (uM):10Peak area
  logo